MicroRNA-133b inhibits cell migration and invasion by targeting matrix metalloproteinase 14 in glioblastoma.

MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma. Biomed Res Int (2017) 0.75

MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17

Identification of novel genes coding for small expressed RNAs. Science (2001) 44.44

A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03

miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer (2010) 3.14

microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget (2012) 1.83

MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem (2007) 1.51

MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res (2011) 1.48

MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell Int (2013) 1.24

MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS One (2013) 1.15

miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression. Mol Cancer (2013) 1.15

MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor. FEBS J (2012) 1.10

miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer. PLoS One (2014) 1.04

miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol (2013) 1.02

Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010. Neuro Oncol (2014) 0.99

Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer. Int J Clin Exp Med (2011) 0.93

Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease. Curr Pharm Des (2007) 0.91

ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth. J Cell Sci (2013) 0.91

MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3. Asian Pac J Cancer Prev (2014) 0.90

Histone deacetylase inhibitor, valproic acid, radiosensitizes the C6 glioma cell line in vitro. Oncol Lett (2013) 0.89

microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma. Mol Med Rep (2014) 0.87

Mechanisms underlying the biological changes induced by isocitrate dehydrogenase-1 mutation in glioma cells. Oncol Lett (2014) 0.87

Effect of silencing HIF-1α on proliferation, invasion and migration of glioblastoma U87 cells. Neurol Sci (2012) 0.84

Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma. Clin Transl Oncol (2012) 0.80

Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades. Med Oncol (2010) 0.80

Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastoma. Oncol Lett (2015) 0.75